Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

In regards to HIV cure. If we listen to NP caref

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155523
(Total Views: 328)
Posted On: 11/22/2019 11:51:33 AM
Posted By: aidenb
Re: ohm20 #11339
In regards to HIV cure.
If we listen to NP carefully, and compare it with what he said a few months ago, we shall know what he is saying regarding cure/functional cure/etc.

Few months ago, he indicated that HIV reserviour stays in the body for 9 years. Sacha is assessing how bone marrow, cures in 1.5 years. It seems to be through GvHD mechanism of action.

Yesterday, he mentioned, cure wont be done anytime soon, and it will take years. Means, the mechanism it theory and on the mice is perfect, but on the human, let's not count on it as it this will never be approved. They did bone marrow transplant on mice, which is a deadly procedure (he did explicitly say this word), and used our drug.

Which translates to :They used Leronlimab, so that the bone marrow transplant will not be deadly.
There is a major issue, that I can understand with my limited knowledge. The patient should be on Leronlimab forever, and god bless the guy if he cannot be. Well, he was not going to die in the first place, who would approve putting him on a high risk to die, if he has issues with Leronlimab and cannot take if forever (or for a long time)

So, again, as NP mentioned yesterday, there is a long way to doing that, and let's forget about it for now. Sacha will publish the studies, will we know will look good on paper, but will not be approved.

If you also remember, just last week, he reiterated that we are talking to white house for Prep, every years 40k new people get HIV and if they have once a week injection they will not have it, and over the time HIV number goes down. He didn't even say anything for cure, regarding they white house approach.

Nevertheless, as NP implicitly keeps reiterating, Leronlimab has so many applications, that we can safely forget about this one for now.


(0)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us